The Assistant Undersecretary for Drug and Food Control Affairs at the Kuwaiti Ministry of Health, Dr. Abdullah Munjid Al-Badr, announced that the Ministry has issued an emergency use license for the “Oxford” anti-corona virus vaccine that is manufactured in a serum factory in India, with a license from the “AstraZnica” company And based on the decision of the Joint Technical Committee between the Department of Registration and Control of Medicinal and Botanical Medicines and the Public Health Department to evaluate and register vaccines and vaccines.
Dr. Al-Badr stated that this vaccine obtained approval from the European Medicines Authority (EMA) and the British Agency MHRA Medicines and Health Products Regulation.
It is noteworthy that the serum factory is a factory approved by the World Health Organization for the manufacture of vaccines and also by the Health Council of the Cooperation Council States.
Dr. Al-Badr said in a press statement that this decision came after a thorough review by the committee Technical data for all data and scientific reports, where the committee conducted a comprehensive assessment of safety, effectiveness and quality information, and reviewed the results of Clinical studies concerned with the effectiveness and safety of the vaccine, in addition to checking quality reports, evaluating product stability studies, and making sure that the principles of good manufacturing are applied in factories producing the vaccine according to international standards to ensure quality at all stages of manufacturing.
And between Dr. Al-Badr said that the review process also included all technical and scientific aspects, stressing that the Ministry of Health will carefully monitor the safety and safety of the vaccine after its use, as well as the Ministry’s continuing to follow up information and data about the safety, effectiveness and quality of the vaccine locally and internationally, and to take the necessary measures to ensure the safety of citizens and residents.
